Bracco Diagnostics
The Bracco Group is an Italian multinational active in the healthcare sector with more than 3,300 employees worldwide, which operates in a variety of business areas.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Cardiogen | Rubidium | 1989-12-29 | — | |
| Cardiografin | Diatrizoate meglumine | 1982-01-01 | — | |
| Chlormerodrin hg | Chlormerodrin hg-197 | 1982-01-01 | — | |
| Cholografin meglumine | Iodipamide meglumine | 1982-01-01 | — | |
| Cholovue | Iodoxamate meglumine | 1982-01-01 | — | |
| Cystografin | Diatrizoate meglumine | 1982-01-01 | — | |
| Entero vu | Barium | 2016-01-15 | — | |
| Gastrografin | Diatrizoate meglumine, Diatrizoic acid | 1982-01-01 | — | |
| Iodotope | Sodium iodide i-131 | 1982-01-01 | ||
| Isovue | Iopamidol | 1985-12-31 | — |
1
2
3
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use